Tag

Lymphoma

All articles tagged with #lymphoma

Sam Neill Laid to Rest: Pneumonia Cited as Cause of Death by Rep
pop-culture1 month ago

Sam Neill Laid to Rest: Pneumonia Cited as Cause of Death by Rep

Sam Neill, the Jurassic Park star, died in Australia at age 78, with his longtime representative confirming the cause of death as pneumonia after he battled lymphoma in 2022 and underwent CAR-T therapy. The family had announced he was cancer-free prior to his passing, describing the death as sudden, and a private memorial is planned at his New Zealand farm as fans await updates amid accompanying rumors.

Sam Neill, Jurassic Park’s Alan Grant, Dies at 78
entertainment1 month ago

Sam Neill, Jurassic Park’s Alan Grant, Dies at 78

Sam Neill, the New Zealand-born actor famed for his role as Dr. Alan Grant in Jurassic Park, died at 78 in Sydney, with his family saying the passing was sudden and that he had been cancer-free after a battle with lymphoma. His career spanned film and TV—from The Piano and Dead Calm to Merlin, Peaky Blinders, and a return in Jurassic World Dominion—alongside his Two Paddocks winery and a 2023 memoir, Did I Ever Tell You This? Tributes flowed from fans and world leaders alike.

Sam Neill, Jurassic Park Star and New Zealand Icon, Dies at 78
world1 month ago

Sam Neill, Jurassic Park Star and New Zealand Icon, Dies at 78

NZ-born actor Sam Neill, famed for Jurassic Park and The Piano, has died in Sydney at 78 in a death described as sudden and unexpected. He had been diagnosed with a rare lymphoma in 2023 but was cancer-free at his passing. Tributes poured in from New Zealand and Australia, honoring his five-decade career that ranged from art films to blockbusters, and noting his later-life vineyard work in Central Otago.

Zynlonta safety signal triggers death spike in confirmatory trial, sending ADC Therapeutics shares tumbling
business2 months ago

Zynlonta safety signal triggers death spike in confirmatory trial, sending ADC Therapeutics shares tumbling

In the LOTIS-5 Phase 3 trial for relapsed/refractory DLBCL, Zynlonta plus rituximab showed a higher death count (27) versus 9 in the control arm among 440 patients, with deaths characterized as treatment-emergent events and not definitively linked to the drug; safety concerns contributed to a more than 50% drop in ADC Therapeutics’ stock to about $1.44, even as the study met its primary endpoint of improved progression-free survival. There was no clear overall survival benefit, though higher response rates were reported. The company said it will discuss a path forward with the FDA and plans a supplemental filing for full approval in Q4.

From Ovarian-Cyst Misread to Stage 4 Lymphoma Remission: A 24-Year-Old's Journey
health5 months ago

From Ovarian-Cyst Misread to Stage 4 Lymphoma Remission: A 24-Year-Old's Journey

After an ER visit for stomach pain was first blamed on an ovarian cyst, Giahan Tang’s CT scan later revealed small lesions that pointed to metastatic disease, and a biopsy confirmed stage 4 diffuse large B-cell lymphoma. The 24-year-old underwent an aggressive treatment plan of chemotherapy, immunotherapy, and steroids, enduring fatigue, hair loss and loss of independence before a PET scan showed no detectable lymphoma. She completed six rounds of treatment and is now cancer-free. Tang has been sharing her journey on TikTok to encourage others to listen to their bodies and value health.

From flu-like symptoms to remission: a lymphoma patient’s CAR-T comeback
health5 months ago

From flu-like symptoms to remission: a lymphoma patient’s CAR-T comeback

A Pilates instructor’s flu-like symptoms led to a diffuse large B-cell lymphoma diagnosis; after initial chemotherapy, the cancer recurred in her brain, but a personalized CAR-T immunotherapy treatment induced complete remission. She experienced no major side effects, returned to daily life, and will continue regular scans to monitor for recurrence, marking a hopeful turnaround.

Toothache Unmasks Aggressive Facial Cancer in 42-Year-Old Man
health5 months ago

Toothache Unmasks Aggressive Facial Cancer in 42-Year-Old Man

A 42-year-old man in the UK discovered via a toothache that he had an aggressive facial cancer. After a mass was found and a CT/biopsy confirmed stage 2 diffuse large B-cell lymphoma, doctors said the tumor had eaten through his facial bone and was inoperable. He began chemotherapy in December but has paused after four rounds due to severe side effects, and he urges others not to ignore minor symptoms that could signal cancer.

cf-EpiTracing maps disease origin and therapy responses from the plasma epigenome
science5 months ago

cf-EpiTracing maps disease origin and therapy responses from the plasma epigenome

Researchers report cf-EpiTracing, an automated platform that profiles multiple histone modifications in cell-free chromatin from as little as 50 μL of plasma to infer tissues of origin with high accuracy; by integrating an 18-ICS ChromHMM framework across reference epigenomes, it identifies primary diseased tissues, detects organ involvement, enables noninvasive cancer subtyping (DLBCL, FL, MCL), early colorectal lesions, prognosis and therapy-response prediction, and tracks disease transformations and translocations. Validated in CRC, CHD and B-cell lymphoma cohorts, cf-EpiTracing outperforms current clinical indices for prognosis and supports longitudinal monitoring, highlighting a versatile, noninvasive epigenome-centric approach that could be integrated with other cfDNA modalities for enhanced precision.

From misdiagnosed fever to remission: a college student's battle with aggressive lymphoma
health5 months ago

From misdiagnosed fever to remission: a college student's battle with aggressive lymphoma

Emma Operacz, a 21-year-old Eastern Michigan University student, went from thinking she had a UTI to a life-threatening stage IV ALK+ anaplastic large cell lymphoma; after a difficult treatment course that included an experimental drug to cross the blood–brain barrier and a sister-donor bone marrow transplant, she spent months recovering before graduating in December 2025 and beginning a graduate program to work with cancer patients.

obituary7 months ago

Broadway Actor and Influencer Bret Hanna-Shuford Passes Away at 46

Bret Hanna-Shuford, a Broadway actor and social media influencer known for his role in productions like Wicked and for documenting his life as a gay parent with his husband Stephen, has died at 46 after battling lymphoma and HLH. He was also working on a children's book and is survived by his family, including his son Maverick.